Unibest
← Back to patent-cliff list

Entacapone

Tier C — Watch / trade

Entacapone

Orion Corporation
Originator
1998
First approval
-
Expiry (public)
$0.02B ▲
Peak sales
Small molecule
Type

Targets:COMT

Brand:Comtess, Comtan

Indications (approved):Parkinson's disease

Regional status

US
Approved
1999-10-19
EU
Approved
1998-09-16
China
Approved
2004-05-08
Japan
Approved
2007-01-26

Synthetic routes & intermediates5 routes

Originator routes × 1Optimised (non-patent) × 4Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 1 · Total yield 2.23 g
ENTA-001116313-85-0ENTA-00226391-06-0ENTA-003618-42-8API · Entacapone
CodeCAS No.Intermediate
ENTA-001116313-85-03,4-dihydroxy-5-nitrobenzaldehyde
ENTA-00226391-06-02-cyano-N,N-diethylacetamide
ENTA-003618-42-81-(piperidin-1-yl)ethanone
OptimisedRoute 2Steps 3 · Total yield 4.00 g
ENTA-001116313-85-0ENTA-004372-09-8ENTA-005160391-70-8ENTA-0061291066-63-1ENTA-007109-89-7API · Entacapone
CodeCAS No.Intermediate
ENTA-001116313-85-03,4-dihydroxy-5-nitrobenzaldehyde
ENTA-004372-09-8Available2-cyanoacetic acid
ENTA-005160391-70-8(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylic acid
ENTA-0061291066-63-1(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acryloyl chloride
ENTA-007109-89-7diethylamine
OptimisedRoute 3Steps 3 · Total yield 0.90 g
ENTA-008203861-62-5ENTA-00953793-77-4ENTA-010893419-47-1ENTA-011857629-78-8API · Entacapone
CodeCAS No.Intermediate
ENTA-008203861-62-54-iodo-2-methoxyphenol
ENTA-00953793-77-42-cyano-N,N-diethylacrylamide
ENTA-010893419-47-1(E)-2-cyano-N,N-diethyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide
ENTA-011857629-78-8(E)-2-cyano-N,N-diethyl-3-(4-hydroxy-3-methoxy-5-nitrophenyl)acrylamide
OptimisedRoute 4Steps 4 · Total yield 105.00 mg
ENTA-00226391-06-0ENTA-01291004-48-7ENTA-013134610-30-3ENTA-0141067233-92-4ENTA-0151067233-93-5API · Entacapone
CodeCAS No.Intermediate
ENTA-00226391-06-02-cyano-N,N-diethylacetamide
ENTA-01291004-48-73,4-dimethoxy-5-nitrobenzoic acid
ENTA-013134610-30-33,4-dimethoxy-5-nitrobenzoyl chloride
ENTA-0141067233-92-4(Z)-2-cyano-3-(3,4-dimethoxy-5-nitrophenyl)-N,N-diethyl-3-hydroxyacrylamide
ENTA-0151067233-93-5(E)-2-cyano-3-(3,4-dimethoxy-5-nitrophenyl)-N,N-diethylacrylamide
OptimisedRoute 5Steps 3 · Total yield 9.45 g
ENTA-001116313-85-0ENTA-00226391-06-0ENTA-004372-09-8ENTA-0166635-20-7API · Entacapone
CodeCAS No.Intermediate
ENTA-001116313-85-03,4-dihydroxy-5-nitrobenzaldehyde
ENTA-00226391-06-02-cyano-N,N-diethylacetamide
ENTA-004372-09-8Available2-cyanoacetic acid
ENTA-0166635-20-74-hydroxy-3-methoxy-5-nitrobenzaldehyde

Frequently asked questions

What are the approved indications of Entacapone?

Approved indications include: Parkinson's disease.

When does the Entacapone patent expire?

No public expiry year is available for Entacapone yet; this page updates once verified.

How many synthesis routes are recorded for Entacapone?

5 synthesis routes are recorded; the shortest is 1 steps with 2.23 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Entacapone intermediates?

1 intermediate CAS of Entacapone are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Entacapone intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29